Purchase Order 75D30123P17176
Award Date 7/19/23
Potential Completion Date 2/15/24
Potential Value $86K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Kent, WA 98032, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $59,293.60 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies, to provide intesticult cell cultures. This contract, which has an ultimate completion date of October 8, 2025, is not set aside for small businesses. Stemcell Technologies Inc. is a key supplier of specialized biological materials, laboratory supplies, scientific equipment, and...
- The Centers for Disease Control and Prevention (CDC) awarded a $249,662 purchase order to Cell Microsystems Inc. to procure cell lines in support of the agency's biomedical research and public health initiatives. The firm fixed price contract has a period of performance from September 11, 2023 through October 30, 2023 for delivery of the requested cell lines to CDC facilities in Durham, North Carolina. No subcontractors or set aside designations were identified. This award advances the CDC's...
- This federal contract award was granted to Stemcell Technologies Inc., a subsidiary of the Canadian biotechnology company Stemcell Technologies, by the Department of Health and Human Services (HHS). The contract, worth $24,908.80, is a firm fixed-price purchase order for the company to provide a range of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various HHS agencies, including the...
- Stemcell Technologies Inc. has been awarded a firm fixed-price purchase order valued at $19,430.40 by the NIH Clinical Center, with an ultimate completion date of December 19, 2026. The contract, which carries no small business set-aside designation, will be performed in Kent, Washington. As a subsidiary of the Canadian biotechnology company Stemcell Technologies, the awardee specializes in providing advanced biological research products and laboratory supplies essential to federal research...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh has awarded a $90,147.50 firm fixed-price purchase order to Government Scientific Source Inc. for the procurement of ready-to-use primary human bronchial and nasal cells. The award was made on September 9, 2024, with an ultimate completion date of September 30, 2025. The contract carries no set-aside designation and will be performed in Chamblee, Georgia. Government Scientific Source Inc., a small business headquartered in Reston,...
- The Centers for Disease Control and Prevention (CDC) awarded Illumina, Inc. a $160,535.84 firm fixed price purchase order for reagents. The CDC, part of the Department of Health and Human Services, will utilize the reagents in Pittsburgh, Pennsylvania as part of its efforts to advance public health. Illumina will deliver the products from its facilities in San Diego, California by September 30, 2023 to support the CDC's disease prevention and health promotion activities. No set aside designation...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $86,313 purchase order to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, for laboratory supplies. The firm fixed price contract runs from July 12, 2023 to October 13, 2023 for delivery of the requested products to the CDC location in Shelton, Connecticut. No subcontractors or set aside designations were identified. The award provides supplies to...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $73,915 purchase order to Nanostring Technologies, Inc. of Atlanta, Georgia for laboratory equipment. The firm fixed price contract runs from July 17, 2023 through October 30, 2023 to deliver the requested products to support CDC programs in Atlanta. No subcontractors or set aside designations were identified. The award provides laboratory equipment to the CDC, which conducts public health...
- This is a $24,970.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which has no set-aside designation, is for the delivery of various cell culture research products, such as cell isolation kits, cell culture media, and automated cell separation instruments, to support biomedical...
- The Centers for Disease Control and Prevention (CDC) awarded a $8,905.97 firm fixed price purchase order to Tecan U.S., Inc. for laboratory equipment. As part of the Department of Health and Human Services (HHS), the CDC works to protect public health and safety through control and prevention of disease, injury, and disability. The equipment will support the CDC's work at its Pittsburgh location and will be delivered to Atlanta, Georgia by September 30, 2023. Tecan will serve as the prime...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $86,359.80 firm fixed price purchase order to Stemcell Technologies Inc. of Kent, Washington for laboratory reagents. The contract runs from July 19, 2023 through February 15, 2024 to support CDC's research and public health programs. As a leading supplier of cell biology reagents and tools, Stemcell will provide the requested products to aid CDC's disease prevention and health promotion efforts. No major subcontractors or set aside designations were indicated. The contract award aligns with CDC's mission to protect public health through global disease monitoring, notifications, and laboratory research.
Generated 12/24/23, 4:14 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $86.4k | 7/19/23 |